Leveragen
Woburn, MA, United States · leveragen.com
CLIA
Leveragen is a Boston-based biotechnology company that develops in vivo platforms for antibody discovery. It works with biotechnology, pharmaceutical, and academic collaborators worldwide from its Massachusetts site and supports therapeutics, diagnostics, and animal health programs.
They take quote requests by email.
What they offer
Antibody platform development
Develops genetically engineered mouse platforms for discovering single-domain, common light-chain, and conventional antibodies.
Antibody discovery collaborations
Supports partner programs with integrated discovery workflows from immunization through hit expansion and early developability assessment.
Customized commercial partnerships
Provides customized commercial structures for collaborators in biotechnology, pharmaceutical, and academic settings.
Genetic model engineering
Creates complex mouse models with conditional alleles, point mutations, targeted replacements, genomic humanization, and gene knockouts.
What they work on
- Modalities
- Antibody, Bispecific, ADC, mRNA, Viral vector, Gene editing
- Species and models
- mouse, human, alpaca, shark, dog, cat
- Assays and studies
- immunization, repertoire capture, phage display, next-generation sequencing, family scanning, hit expansion, recombinant expression, early developability assessment
- Therapeutic areas
- therapeutics, diagnostics, animal health
- Sites
- Woburn, United States · Boston, United States
- Serves
- globally
Similar labs. Invenra, AbTherx, Probiocdmo, Sparx BIO
Found in a contract services directory. Listing built from leveragen.com. Work here? Claim this listing.